Nancy M Holekamp (Nancy Holekamp)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Medical Education

Optical Coherence Tomography

Age Related Macular Degeneration

Top Venues

Ophthalmology and therapy

Expert opinion on biological therapy

Patient preference and adherence

Retina (Philadelphia, Pa.)

This page only lists publications with an associated author ORCID identifier.

Publications

Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, Ronald A Cantrell, Sheena Singh, Gus Gazzard
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. Ophthalmology and therapy 13 (9) (2024)
Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, Ronald A Cantrell, Sheena Singh, Gus Gazzard
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. Ophthalmology and therapy 13 (9) (2024)
Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, Ronald A Cantrell, Sheena Singh, Gus Gazzard
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. Ophthalmology and therapy (2024)
Nancy M Holekamp, Anthony M de Beus, W Lloyd Clark, Jeffrey S Heier
PROSPECTIVE TRIAL OF HOME OPTICAL COHERENCE TOMOGRAPHY-GUIDED MANAGEMENT OF TREATMENT EXPERIENCED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS. Retina (Philadelphia, Pa.) 44 (10) (2024)
Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, Ronald A Cantrell, Sheena Singh, Gus Gazzard
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. Ophthalmology and therapy 13 (9) (2024)
Ashish Sharma, Frank G Holz, Carl D Regillo, K Bailey Freund, David Sarraf, Arshad M Khanani, Caroline Baumal, Nancy M Holekamp, Ramin Tadayoni, Nilesh Kumar, Nikulaa Parachuri, Baruch D Kuppermann, null null, null null, Francesco Bandello, Giuseppe Querques, Anat Loewenstein, Şengül Özdek, Kourous Rezai, Kodjikian Laurent, Alper Bilgic, Paolo Lanzetta, Dinah Zur, Nicolas Yannuzzi, Giulia Corradetti, Peter Kaiser, Assaf Hilely, David Boyer, Aleksandra Rachitskaya, Usha Chakravarthy, Maximilian Wintergerst, Valentina Sarao, Barbara Parolini, Prithvi Mruthyunjaya, Quan Dong Nguyen, Diana DO, Pearse A Keane, Tarek Hassan, Jayanth Sridhar, David Eichenbaum, Dilraj Grewal, Martin Splitzer
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey). Expert opinion on biological therapy (2023)
Ashish Sharma, Frank G Holz, Carl D Regillo, K Bailey Freund, David Sarraf, Arshad M Khanani, Caroline Baumal, Nancy M Holekamp, Ramin Tadayoni, Nilesh Kumar, Nikulaa Parachuri, Baruch D Kuppermann
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey). Expert opinion on biological therapy (2023)
Ashish Sharma, Frank G Holz, Carl D Regillo, K Bailey Freund, David Sarraf, Arshad M Khanani, Caroline Baumal, Nancy M Holekamp, Ramin Tadayoni, Nilesh Kumar, Nikulaa Parachuri, Baruch D Kuppermann, null null
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey). Expert opinion on biological therapy (2023)
Audrey Giocanti-Aurégan, Alfredo García-Layana, Tunde Peto, Brittany Gentile, Gloria C Chi, Mirela Mirt, Charlotte E Kosmas, Jeremy Lambert, Sally Lanar, Hannah B Lewis, Nancy M Holekamp
Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study. Patient preference and adherence 16 (2022)
Nancy M Holekamp, Steven B Duff, Yamina Rajput, Vincent Garmo
Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data. Journal of medical economics 23 (3) (2019)